Work

OA12.02 Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer

Year: 2018

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.08.300

Authors: A. Drilon, J. Clark, J. Weiss, S. Ou, D.R. Camidge, B. Solomon, G. Otterson, L. Villaruz, G. Riely, R. Heist, G. Shapiro, D. Murphy, S. Wang, T. Usari, S. Li, K. Wilner, P. Paik

Institutions: Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, University of North Carolina at Chapel Hill, University of California, Irvine, University of Colorado Denver, Peter MacCallum Cancer Centre, The Ohio State University, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Dana-Farber Cancer Institute, Pfizer (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2898260831

Cites:

Cited by: 35

Related to: 10